Document Classification

Section Type: METHODS

Text: Between April 1989 and May 1995, 204 patients with medically inoperable or technically unresectable NSCLC localised to the primary site and regional lymph nodes were randomised to receive one of four treatments using a 2 x 2 factorial design : standard radiotherapy, 60 Gy in 30 fractions in 6 weeks (R6) ; accelerated radiotherapy, 60 Gy in 30 fractions in 3 weeks (R3) ; standard radiotherapy as in R6 with carboplatin 70 mg/m2/day for 5 days during weeks 1 and 5 of radiotherapy (R6C) ; accelerated radiotherapy as in R3 with carboplatin 70 mg/m2/day for 5 days during week 1 of radiotherapy (R3C).